Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

breast ultrasound biopsy

Find It Early Act takes flight on Capitol Hill

Women with dense breasts or other heightened risk factors for breast cancer may be on the cusp of receiving 100% coverage for additional imaging beyond standard mammography.

insurance payer payment insurer

CMS proposes ACA expansion on behavioral health, special enrollment

 The revisions impact insurers operating on the Affordable Care Act marketplace.

Thumbnail

Experts offer tips for improving breast density notifications

These notifications can sometimes leave many patients feeling even more bewildered about their mammogram results than they were before being made aware of their dense tissue.

Thumbnail

Millions will lose Medicaid coverage when COVID-19 PHE ends

The PHE has been in effect since the early days of the pandemic, and it has been reaffirmed every 90 days since. CMS has indicated it will give healthcare stakeholders at least 60 days’ notice before winding down the PHE.

Thumbnail

U.S. lawmakers pen letter calling for expanded access to amyloid PET imaging

“We must make every effort to grant equitable access to tools that can help individuals and their loved ones treat and manage this disease."

Thumbnail

Price transparency a hot topic, but many patients still caught off guard by imaging bills

Many patients are unaware of factors that influence how they are billed, such as ancillary fees and organizational setups that use parties offsite to interpret imaging studies. In turn, the pricing information patients receive prior to exams is often incomplete. 

Congress focused on mental health, Medicare price negotiations as 2023 approaches

With the midterms in the rearview, the lameduck Congress is focused on a handful of healthcare priorities heading into 2023, including mental health and implementing recent Medicare price negotiations afforded in the Inflation Reduction Act.

Products from Avenda Health, Imagen Technologies, Ultromics OK’d for use in the US

An AI startup has been cleared to market a platform for precisely mapping prostate cancer with 3D visualization so the tumor can be treated without harm to healthy surrounding prostate tissue.